| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OBLN | OBALON THERAPEUTICS INC | Brister Mark | Chief Technology Officer | Aug 06, 2019 | Buy | $4.00 | 5,000 | 20,000 | 38,865 | Aug 08, 2019, 02:28 PM | |
| OBLN | OBALON THERAPEUTICS INC | Brister Mark | Chief Technology Officer | Aug 23, 2018 | Option Exercise | $1.82 | 107,142 | 194,998 | 338,634 | Aug 27, 2018, 09:34 PM | |
| OBLN | OBALON THERAPEUTICS INC | Brister Mark | Chief Technology Officer | Apr 30, 2018 | Option Exercise | $3.27 | 2,622 | 8,574 | 166,492 | May 02, 2018, 07:23 AM | |
| OBLN | OBALON THERAPEUTICS INC | Brister Mark | Chief Technology Officer | Oct 31, 2017 | Option Exercise | $7.17 | 1,860 | 13,336 | 163,870 | Nov 02, 2017, 02:23 PM | |
| OBLN | OBALON THERAPEUTICS INC | Brister Mark | VP of Research and Development | Apr 30, 2017 | Option Exercise | $9.03 | 1,550 | 13,996 | 162,010 | May 02, 2017, 06:52 PM |
Menu